Smith & Nephew
SNN · NYSE
Bulios Fair Price
$25.56
3.3% downside
Current Price
$26.43
According to Bulios Fair Price, SNN is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Smith & Nephew plc (SN) is a British company specializing in the manufacture and distribution of healthcare devices and surgical products. Their portfolio includes a wide range of products in the fields of orthopedics, sports medicine, joint surgery, traumatology, and advanced surgical technologies. The company manufactures and supplies implants, prosthetics, instruments, and devices for orthopedic surgeries, as well as products for wound care, skin care, and other surgical needs. Smith & Nephew focuses on providing innovative and high-quality products that help physicians achieve better outcomes for their patients. The company also invests in research and development of new technologies and products to continuously innovate and improve its portfolio. Smith & Nephew plc (SN) shares may be attractive to investors seeking investments in companies operating in the healthcare devices sector with a wide range of products and an emphasis on innovation and quality.
Sector
Healthcare
Industry
Medical - Devices
CEO
Deepak S. Nath
Employees
18,362
Headquarters
Watford
Upcoming events
Earnings
Upcoming earnings report